Cite

HARVARD Citation

    Tuxen, M. et al. (2014). Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer. Acta oncologica. pp. 1440-1445. [Online]. 
  
Back to record